Published in Pain Pract on November 02, 2010
Clinical features of headache patients with fibromyalgia comorbidity. J Headache Pain (2011) 0.94
Why should gastroenterologists know about fibromyalgia? Common pathogenesis and clinical implications. J Neurogastroenterol Motil (2011) 0.75
Gender Differences in Symptoms, Health-Related Quality of Life, Sleep Quality, Mental Health, Cognitive Performance, Pain-Cognition, and Positive Health in Spanish Fibromyalgia Individuals: The Al-Ándalus Project. Pain Res Manag (2016) 0.75
The effects of long- and short-term interdisciplinary treatment approaches in women with fibromyalgia: a randomized controlled trial. Rheumatol Int (2016) 0.75
Healthcare Costs and Medication Adherence Among Patients with Fibromyalgia: Combination Medication vs. Duloxetine, Milnacipran, Venlafaxine, and Pregabalin Initiators. Pain Pract (2017) 0.75
Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA (2002) 8.28
The natural history and prognosis of neovascular age-related macular degeneration: a systematic review of the literature and meta-analysis. Ophthalmology (2007) 2.46
Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis. BMC Ophthalmol (2010) 2.32
Burden and health care resource utilization in neovascular age-related macular degeneration: findings of a multicountry study. Arch Ophthalmol (2007) 1.94
Minimal clinically important difference in the fibromyalgia impact questionnaire. J Rheumatol (2009) 1.88
Effect of treating erectile dysfunction on management of systolic hypertension. Am J Cardiol (2007) 1.46
Trends in utilization of lipid- and blood pressure-lowering agents and goal attainment among the U.S. diabetic population, 1999-2008. Cardiovasc Diabetol (2011) 1.45
Medical services for clients in community mental health centers: results from a national survey. Psychiatr Serv (2008) 1.37
Metabolic screening after the American Diabetes Association's consensus statement on antipsychotic drugs and diabetes. Diabetes Care (2009) 1.30
Evaluation of the safety and efficacy of pregabalin in older patients with neuropathic pain: results from a pooled analysis of 11 clinical studies. BMC Fam Pract (2010) 1.21
Economic burden of bilateral neovascular age-related macular degeneration: multi-country observational study. Pharmacoeconomics (2008) 1.20
The comparative burden of mild, moderate and severe fibromyalgia: results from a cross-sectional survey in the United States. Health Qual Life Outcomes (2011) 1.19
Burden of illness of neovascular age-related macular degeneration in Canada. Can J Ophthalmol (2007) 1.18
Food fermentations: microorganisms with technological beneficial use. Int J Food Microbiol (2011) 1.12
Health Care Costs Among Renal Cancer Patients Using Pazopanib and Sunitinib. J Manag Care Spec Pharm (2015) 1.07
Validity of 24-h recall ratings of pain severity: biasing effects of "Peak" and "End" pain. Pain (2007) 1.05
Impact of fibromyalgia severity on health economic costs: results from a European cross-sectional study. Appl Health Econ Health Policy (2011) 1.05
Effect of patient-centered communication training on discussion and detection of nonadherence in glaucoma. Ophthalmology (2010) 1.03
Health-resource use and costs associated with fibromyalgia in France, Germany, and the United States. Clinicoecon Outcomes Res (2013) 1.01
The comparative economic burden of mild, moderate, and severe fibromyalgia: results from a retrospective chart review and cross-sectional survey of working-age U.S. adults. J Manag Care Pharm (2012) 1.01
Doctor-patient communication in glaucoma care: analysis of videotaped encounters in community-based office practice. Ophthalmology (2009) 0.94
Adherence to varenicline and associated smoking cessation in a community-based patient setting. J Manag Care Pharm (2013) 0.94
Identification of symptom and functional domains that fibromyalgia patients would like to see improved: a cluster analysis. BMC Musculoskelet Disord (2010) 0.94
Clinical comorbidities, treatment patterns, and healthcare costs among patients with fibromyalgia newly prescribed pregabalin or duloxetine in usual care. J Med Econ (2011) 0.93
Dose trends for second-generation antipsychotic treatment of schizophrenia and bipolar disorder. Schizophr Res (2008) 0.93
Patterns of healthcare utilization and cost in patients with newly diagnosed fibromyalgia. Am J Manag Care (2010) 0.92
Evaluation of the impact of fibromyalgia on patients' sleep and the content validity of two sleep scales. Health Qual Life Outcomes (2009) 0.92
Evaluation of cardiovascular morbidity associated with adherence to atorvastatin therapy. Am J Ther (2012) 0.91
Treatment patterns among physician specialties in the management of fibromyalgia: results of a cross-sectional study in the United States. Curr Med Res Opin (2011) 0.91
Burden of fibromyalgia and comparisons with osteoarthritis in the workforce. J Occup Environ Med (2009) 0.91
Burden of illness of bilateral neovascular age-related macular degeneration in Spain. Curr Med Res Opin (2008) 0.88
Real-world comparison of major bleeding risk among non-valvular atrial fibrillation patients initiated on apixaban, dabigatran, rivaroxaban, or warfarin. A propensity score matched analysis. Thromb Haemost (2016) 0.87
Reduction in opioid-related adverse events and improvement in function with parecoxib followed by valdecoxib treatment after non-cardiac surgery: a randomized, double-blind, placebo-controlled, parallel-group trial. Clin Drug Investig (2009) 0.87
Photodynamic therapy with verteporfin in age-related macular degeneration: a systematic review of efficacy, safety, treatment modifications and pharmacoeconomic properties. Acta Ophthalmol (2008) 0.87
Evaluation of cardiovascular disease burden and therapeutic goal attainment in US adults with chronic kidney disease: an analysis of national health and nutritional examination survey data, 2001-2010. BMC Nephrol (2013) 0.87
Prevalence of diagnosed opioid abuse and its economic burden in the veterans health administration. Pain Pract (2013) 0.87
Clinical characteristics, pharmacotherapy and healthcare resource use among patients with fibromyalgia newly prescribed gabapentin or pregabalin. Pain Pract (2009) 0.86
Evaluation of erectile dysfunction therapy in patients previously nonadherent to long-term medications: a retrospective analysis of prescription claims. Am J Ther (2005) 0.85
The prevalence of diagnosed opioid abuse in commercial and Medicare managed care populations. Pain Pract (2013) 0.85
Prevalence of pulmonary arterial hypertension in patients with connective tissue diseases: a systematic review of the literature. Clin Rheumatol (2013) 0.85
Clinical characteristics, pharmacotherapy, and healthcare resource use among patients with fibromyalgia newly prescribed pregabalin or tricyclic antidepressants. J Med Econ (2011) 0.84
Cost effectiveness of pregabalin in the treatment of fibromyalgia from a UK perspective. Curr Med Res Opin (2010) 0.84
Pain responder analysis: use of area under the curve to enhance interpretation of clinical trial results. Pain Pract (2009) 0.83
Prescription opioid abuse and tampering in the United States: results of a self-report survey. Pain Med (2014) 0.83
Prevalence and cost of diagnosed opioid abuse in a privately insured population in the United States. J Opioid Manag (2013) 0.82
Mortality associated with gastrointestinal bleeding events: Comparing short-term clinical outcomes of patients hospitalized for upper GI bleeding and acute myocardial infarction in a US managed care setting. Clin Exp Gastroenterol (2009) 0.82
The effect of azithromycin on ivermectin pharmacokinetics--a population pharmacokinetic model analysis. PLoS Negl Trop Dis (2008) 0.82
Inefficiencies in osteoarthritis and chronic low back pain management. Am J Manag Care (2013) 0.82
The cost-effectiveness of pregabalin in the treatment of fibromyalgia: US perspective. J Med Econ (2012) 0.81
Societal and individual burden of illness among fibromyalgia patients in France: association between disease severity and OMERACT core domains. BMC Musculoskelet Disord (2012) 0.81
Clinical characteristics, pharmacotherapy, and healthcare resource use among patients with diabetic neuropathy newly prescribed pregabalin or gabapentin. Pain Pract (2011) 0.81
Toward characterization and definition of fibromyalgia severity. BMC Musculoskelet Disord (2010) 0.81
Incidence of new coding for dry eye and ocular infection in open-angle glaucoma and ocular hypertension patients treated with prostaglandin analogs: retrospective analysis of three medical/pharmacy claims databases. BMC Ophthalmol (2011) 0.81
Tracking low back problems in a major self-insured workforce: toward improvement in the patient's journey. J Occup Environ Med (2014) 0.81
Simplifying Fibromyalgia Assessment: The VASFIQ Brief Symptom Scale. Ther Adv Musculoskelet Dis (2011) 0.81
Correlations between fibromyalgia symptom and function domains and patient global impression of change: a pooled analysis of three randomized, placebo-controlled trials of pregabalin. Pain Med (2011) 0.81
Extended anticoagulation with apixaban reduces hospitalisations in patients with venous thromboembolism. An analysis of the AMPLIFY-EXT trial. Thromb Haemost (2015) 0.80
Initial use of pregabalin, patterns of pain-related pharmacotherapy, and healthcare resource use among older patients with fibromyalgia. Am J Manag Care (2010) 0.80
Systematic literature review and meta-analysis of the efficacy and safety of prescription opioids, including abuse-deterrent formulations, in non-cancer pain management. Pain Med (2013) 0.80
Venous thromboembolism prophylaxis and clinical consequences in medically ill patients. Am J Ther (2013) 0.80
Use of electronic health records for early detection of high-cost, low back pain patients. Pain Res Manag (2015) 0.80
Impact of an integrated intervention program on atorvastatin adherence: a randomized controlled trial. Int J Gen Med (2013) 0.79
Real-world evaluation of health-care resource utilization and costs in employees with fibromyalgia treated with pregabalin or duloxetine. Pain Pract (2010) 0.79
Pain conditions ranked by healthcare costs for members of a national health plan. Pain Pract (2013) 0.79
Newly diagnosed exudative age-related macular degeneration treated with pegaptanib sodium monotherapy in US community-based practices: medical chart review study. BMC Ophthalmol (2010) 0.78
Warfarin Discontinuation in Patients With Unprovoked Venous Thromboembolism: A Large US Insurance Database Analysis. Am J Ther (2015) 0.78
Impact of real-world ziprasidone dosing on treatment discontinuation rates in patients with schizophrenia or bipolar disorder. Schizophr Res (2009) 0.78
Retrospective evaluation of clinical characteristics, pharmacotherapy and healthcare resource use among patients prescribed pregabalin or duloxetine for diabetic peripheral neuropathy in usual care. Pain Pract (2010) 0.78
Prospective observational study of patient-reported outcomes for azithromycin versus usual care in the treatment of bacterial acute exacerbation of chronic bronchitis. Clin Ther (2005) 0.78
Relationships between changes in pain severity and other patient-reported outcomes: an analysis in patients with posttraumatic peripheral neuropathic pain. Health Qual Life Outcomes (2011) 0.78
Evaluation of the Relationship Between Serum Uric Acid Levels and Cardiovascular Events in Patients With Gout: A Retrospective Analysis Using Electronic Medical Record Data. J Clin Rheumatol (2017) 0.78
Building data quality into clinical trials. J AHIMA (2002) 0.77
Evaluation of healthcare resource utilization and costs in employees with pain associated with diabetic peripheral neuropathy treated with pregabalin or duloxetine. J Med Econ (2010) 0.77
Further qualification of a therapeutic responder index for patients with chronic low back pain. J Rheumatol (2010) 0.77
Developing a collaborative study protocol for combining payer-specific data and clinical trials for CER. J Manag Care Pharm (2011) 0.77
Applying area-under-the-curve analysis to enhance interpretation of response profiles: an application to sleep quality scores in patients with fibromyalgia. Qual Life Res (2010) 0.76
Discontinuation/Interruption of Warfarin Therapy in Patients with Nonvalvular Atrial Fibrillation. J Manag Care Spec Pharm (2015) 0.76
Differences in healthcare utilization and associated costs between patients prescribed vs. nonprescribed opioids during an inpatient or emergency department visit. Pain Pract (2013) 0.76
Costs of pregabalin or gabapentin for painful diabetic peripheral neuropathy. J Med Econ (2012) 0.76
Identification of patients with painful diabetic peripheral neuropathy who have a favorable cost profile with pregabalin treatment. Pain Pract (2012) 0.76
Cost-utility of celecoxib use in different treatment strategies for osteoarthritis and rheumatoid arthritis from the Quebec healthcare system perspective. J Med Econ (2009) 0.76
Joint assessment of intended and unintended effects of medications: an example using vascular endothelial growth factor inhibitors for neovascular age-related macular degeneration. J Ophthalmol (2010) 0.75
A multicenter, retrospective chart review study comparing index therapy change rates in open-angle glaucoma or ocular hypertension patients newly treated with latanoprost or travoprost-Z monotherapy. BMC Ophthalmol (2011) 0.75
Assessment of measurement properties of peak VO(2) in children with pulmonary arterial hypertension. BMC Pulm Med (2012) 0.75
Cost drivers of prescription opioid abuse in commercial and Medicare populations. Pain Pract (2013) 0.75
Estimating the economic benefits of positive shifts in fibromyalgia severity: an exploratory analysis based on modeling of clinical trial data of pregabalin. J Med Econ (2012) 0.75
Costs and Work Loss Burden of Diagnosed Opioid Abuse Among Employees on Workers Compensation or Short-term Disability. J Occup Environ Med (2016) 0.75
Effectiveness and safety of apixaban versus warfarin in non-valvular atrial fibrillation patients in "real-world" clinical practice. A propensity-matched analysis of 76,940 patients. Thromb Haemost (2017) 0.75
Infrastructure requirements for secondary data sources in comparative effectiveness research. J Manag Care Pharm (2011) 0.75
Moving branded statins to lowest copay tier improves patient adherence. J Manag Care Pharm (2014) 0.75
Molecular testing patterns in metastatic non-small cell lung cancer. Am J Manag Care (2016) 0.75
Effects of copayment on initiation of smoking cessation pharmacotherapy: an analysis of varenicline reversed claims. Clin Ther (2011) 0.75